Are companies financially superior more willing to comply with social obligations? A perspective based on the heterogeneity of the listed pharmaceutical enterprises in China

Anxia Wan, Qianqian Huang, Yinyin Zhao and Benhong Peng

Managerial and Decision Economics, 2022, vol. 43, issue 6, 1672-1683

Abstract: Reports of social responsibilities of listed pharmaceutical enterprises in China from 2014 to 2018 were selected as examples to analyze the impact of financial performance on CSR undertaken by listed pharmaceutical enterprises under the background of enterprise heterogeneity. For enterprises that display homogeneity, listed pharmaceutical enterprises richer in money have a nonlinear relationship compared against social responsibilities; in contrast, for enterprise proprietorship demonstrating heterogeneity, state‐owned listed pharmaceutical enterprises (SOEs) better in financial performance are more willing to undertake CSR, while among non‐state‐owned companies (non‐SOEs), financial performance shows an inverted “U” nonlinear relationship with CSR.

Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://doi.org/10.1002/mde.3479

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:wly:mgtdec:v:43:y:2022:i:6:p:1672-1683

Access Statistics for this article

Managerial and Decision Economics is currently edited by Antony Dnes

More articles in Managerial and Decision Economics from John Wiley & Sons, Ltd.
Bibliographic data for series maintained by Wiley Content Delivery ().